Li G - Search Results

1

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.

Kandel S, Adhikary P, Li G, Cheng K. Kandel S, et al. Among authors: li g. Cancer Lett. 2021 Jul 10;510:67-78. doi: 10.1016/j.canlet.2021.04.011. Epub 2021 Apr 22. Cancer Lett. 2021. PMID: 33895262 Free PMC article.

2

Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.

Qian D, Lu Z, Xu Q, Wu P, Tian L, Zhao L, Cai B, Yin J, Wu Y, Staveley-O'Carroll KF, Jiang K, Miao Y, Li G. Qian D, et al. Among authors: li g. Cancer Lett. 2017 Jul 1;397:43-51. doi: 10.1016/j.canlet.2017.03.024. Epub 2017 Mar 21. Cancer Lett. 2017. PMID: 28336327

3

Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death.

Liu X, Huang Y, Yuan H, Qi X, Manjunath Y, Avella D, Kaifi JT, Miao Y, Li M, Jiang K, Li G. Liu X, et al. Among authors: li g, li m. Cancer Lett. 2019 Jul 10;454:204-214. doi: 10.1016/j.canlet.2019.04.022. Epub 2019 Apr 17. Cancer Lett. 2019. PMID: 31004701

4

Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.

Qi X, Yang M, Ma L, Sauer M, Avella D, Kaifi JT, Bryan J, Cheng K, Staveley-O'Carroll KF, Kimchi ET, Li G. Qi X, et al. Among authors: li g. J Immunother Cancer. 2020 Oct;8(2):e001038. doi: 10.1136/jitc-2020-001038. J Immunother Cancer. 2020. PMID: 33115942 Free PMC article.

5

Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.

Li Y, Zhao Z, Lin CY, Liu Y, Staveley-OCarroll KF, Li G, Cheng K. Li Y, et al. Among authors: li g. Theranostics. 2021 Jan 1;11(5):2182-2200. doi: 10.7150/thno.53102. eCollection 2021. Theranostics. 2021. PMID: 33500719 Free PMC article.

6

LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis.

Liu X, Yuan H, Zhou J, Wang Q, Qi X, Bernal C, Avella D, Kaifi JT, Kimchi ET, Timothy P, Cheng K, Miao Y, Jiang K, Li G. Liu X, et al. Among authors: li g. Front Cell Dev Biol. 2021 Mar 8;9:647387. doi: 10.3389/fcell.2021.647387. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33763427 Free PMC article.

7

Epigenetic Regulation of Cancer Immune Cells.

Avella Patino DM, Radhakrishnan V, Suvilesh KN, Manjunath Y, Li G, Kimchi ET, Staveley-O'Carroll KF, Warren WC, Kaifi JT, Mitchem JB. Avella Patino DM, et al. Among authors: li g. Semin Cancer Biol. 2022 Aug;83:377-383. doi: 10.1016/j.semcancer.2021.06.022. Epub 2021 Jun 26. Semin Cancer Biol. 2022. PMID: 34182142 Review.

8

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

Liu H, Liu Y, Zhao Z, Li Y, Mustafa B, Chen Z, Barve A, Jain A, Yao X, Li G, Cheng K. Liu H, et al. Among authors: li y, li g. Front Immunol. 2022 Apr 4;13:838966. doi: 10.3389/fimmu.2022.838966. eCollection 2022. Front Immunol. 2022. PMID: 35444660 Free PMC article.

9

Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.

Fetse J, Zhao Z, Liu H, Mamani UF, Mustafa B, Adhikary P, Ibrahim M, Liu Y, Patel P, Nakhjiri M, Alahmari M, Li G, Cheng K. Fetse J, et al. Among authors: li g. J Med Chem. 2022 Sep 22;65(18):12002-12013. doi: 10.1021/acs.jmedchem.2c00539. Epub 2022 Sep 6. J Med Chem. 2022. PMID: 36067356 Free PMC article.

10

A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance.

Zhou J, Lyu N, Wang Q, Yang M, Kimchi ET, Cheng K, Joshi T, Tukuli AR, Staveley-O'Carroll KF, Li G. Zhou J, et al. Among authors: li g. Cancer Lett. 2023 Dec 1;578:216457. doi: 10.1016/j.canlet.2023.216457. Epub 2023 Oct 19. Cancer Lett. 2023. PMID: 37865162 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46,026 results

Search Page